November 14, 2024CorporateTerumo Blood and Cell Technologies Unlocks New Chapter of Localization in China to Facilitate Blood and Cell Treatment Options for Patients
November 12, 2024CorporateTerumo Blood and Cell Technologies Merges Therapeutics Units to Enhance Patient Care Across Treatment JourneyNew Global Therapy Innovations business unit, led by Veerle d’Haenens, aims to unify therapeutic apheresis and cell and gene therapy expertise to expand therapeutic possibilities
November 07, 2024FinancialNotice Concerning Revisions to Full-Year Consolidated Financial Guidance for Fiscal Year Ending March 31, 2025 (FY2024) (PDF 85.27 KB)
November 10, 2022 Presentation regarding Financial Results for the First Half of FYE 3/2023 August 12, 2022 Q&A regarding Financial Results for the First Quarter of FYE 3/2023 August 10, 2022 Audio webcast regarding Financial Results for the First Quarter of FYE 3/2023 August 09, 2022 Presentation regarding Financial Results for the First Quarter of FYE 3/2023 July 15, 2022 Notice of Completion of Disposal of Treasury Shares as Restricted Stock Remuneration Plan (PDF 99.92 KB) July 15, 2022 Notice Concerning the Determination of Details of Issuance of Stock Options (Share Warrants) (PDF 64.64 KB) June 22, 2022 Notice Regarding Disposal of Treasury Shares as Restricted Stock Remuneration (PDF 129.04 KB) June 22, 2022 Notice Concerning the Issuance of Stock Options (Share Warrants) (PDF 108.34 KB) May 16, 2022 Q&A regarding Financial Results for FYE 3/2022 May 13, 2022 Audio webcast regarding Financial Results for FYE 3/2022 May 12, 2022 Presentation regarding Financial Results for FYE 3/2022 February 09, 2022 Terumo Revises its Full-Year Financial Guidance for FY2021 (PDF 77.4 KB) November 04, 2021 Terumo Revises Interim Dividend Distribution and Year-End Dividends Forecast for Fiscal Year Ending March 31, 2022 (PDF 77.23 KB) May 12, 2021 Terumo Announces Dividends for Fiscal Year Ended March 31, 2021 (increased payment) (PDF 219.26 KB) February 24, 2021 Terumo Signs a Definitive Agreement to Acquire All Assets of Health Outcomes Sciences, Inc. Transaction furthers Terumo’s efforts to improve patient outcomes and decrease healthcare costs through personalized predictive analytics and clinical decision support at the point of care February 04, 2021 Terumo Revises its Full-Year Financial Guidance for FY2020 (PDF 223.72 KB) Pagination Previous page ‹ Page1 Current page2 Next page ›
July 15, 2022 Notice of Completion of Disposal of Treasury Shares as Restricted Stock Remuneration Plan (PDF 99.92 KB)
July 15, 2022 Notice Concerning the Determination of Details of Issuance of Stock Options (Share Warrants) (PDF 64.64 KB)
June 22, 2022 Notice Regarding Disposal of Treasury Shares as Restricted Stock Remuneration (PDF 129.04 KB)
November 04, 2021 Terumo Revises Interim Dividend Distribution and Year-End Dividends Forecast for Fiscal Year Ending March 31, 2022 (PDF 77.23 KB)
May 12, 2021 Terumo Announces Dividends for Fiscal Year Ended March 31, 2021 (increased payment) (PDF 219.26 KB)
February 24, 2021 Terumo Signs a Definitive Agreement to Acquire All Assets of Health Outcomes Sciences, Inc. Transaction furthers Terumo’s efforts to improve patient outcomes and decrease healthcare costs through personalized predictive analytics and clinical decision support at the point of care
Top
Top